(Z)-2-((Furan-2-ylmethyl)sulfinyl)-N-(4-((4-(piperidin-1-ylmethyl)pyridin-2-yl)oxy)but-2-en-1-yl)acetamide

Catalog No. :
ACSMJY941
CAS No. :
206449-93-6
Molecular Formula :
C22H29N3O4S
Molecular Weight :
431.56

IUPAC Name:(Z)-2-((furan-2-ylmethyl)sulfinyl)-N-(4-((4-(piperidin-1-ylmethyl)pyridin-2-yl)oxy)but-2-en-1-yl)acetamide

(Z)-2-((Furan-2-ylmethyl)sulfinyl)-N-(4-((4-(piperidin-1-ylmethyl)pyridin-2-yl)oxy)but-2-en-1-yl)acetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$88.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(Z)-2-((Furan-2-ylmethyl)sulfinyl)-N-(4-((4-(piperidin-1-ylmethyl)pyridin-2-yl)oxy)but-2-en-1-yl)acetamide
IUPAC Name(Z)-2-((furan-2-ylmethyl)sulfinyl)-N-(4-((4-(piperidin-1-ylmethyl)pyridin-2-yl)oxy)but-2-en-1-yl)acetamide
Molecular FormulaC22H29N3O4S
Molecular Weight431.56
SMILESO=S(CC1=CC=CO1)CC(NC/C=C\COC2=CC(CN3CCCCC3)=CC=N2)=O
InChI KeyKMZQAVXSMUKBPD-DJWKRKHSSA-N
Synonymrac Lafutidine;(Z)-Lafutidine;(Z)-FRG-8813
CAS No.206449-93-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACSMJY941 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACSMJY941 route product structure diagram
    ACSMJY941206449-93-6 In Stock
Inquiry

2. ACSMJY941 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACDHWT408 route compound structure diagram
    ACDHWT408108499-26-9 In Stock
  4. Then
  5. ACSMJY941 route product structure diagram
    ACSMJY941206449-93-6 In Stock
Inquiry

Comments (0)